GITNUXREPORT 2026

Ivd Diagnostics Industry Statistics

The IVD diagnostics market is large, growing steadily, and dominated by reagents and routine testing.

Gabrielle Fontaine

Written by Gabrielle Fontaine·Edited by Marcus Engström·Fact-checked by Abigail Foster

Published Feb 13, 2026·Last verified Apr 3, 2026·Next review: Oct 2026

How We Build This Report

01
Primary Source Collection

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02
Editorial Curation

Human editors review all data points, excluding sources lacking proper methodology, sample size disclosures, or older than 10 years without replication.

03
AI-Powered Verification

Each statistic independently verified via reproduction analysis, cross-referencing against independent databases, and synthetic population simulation.

04
Human Cross-Check

Final human editorial review of all AI-verified statistics. Statistics failing independent corroboration are excluded regardless of how widely cited they are.

Statistics that could not be independently verified are excluded regardless of how widely cited they are elsewhere.

Our process →

Key Statistics

Statistic 1

Infectious diseases application held the largest market share of 28.4% in the IVD market in 2022, boosted by COVID-19 diagnostics.

Statistic 2

Oncology IVD market share was 22.1% in 2022 within disease diagnostics applications.

Statistic 3

Diabetes management IVD applications generated USD 12.4 billion in revenue in 2022.

Statistic 4

Cardiology diagnostics in IVD accounted for 15.7% application market share in 2022.

Statistic 5

Autoimmune diseases IVD testing market share was 11.3% in 2022.

Statistic 6

Nephrology IVD applications contributed 9.2% market share in 2022.

Statistic 7

Neurology diagnostics IVD share was 7.5% in 2022 applications.

Statistic 8

Gastroenterology IVD market share 6.8% in 2022.

Statistic 9

Respiratory diseases IVD testing surged to 18.9% share post-COVID in 2022.

Statistic 10

Drug testing IVD applications 10.4% market share in 2022.

Statistic 11

Endocrinology IVD testing 13.6% share in 2022 applications.

Statistic 12

Rheumatology IVD share 5.2% in 2022.

Statistic 13

Hematology testing IVD 14.8% application share 2022.

Statistic 14

Infectious disease POCT 42.7% share in applications 2022.

Statistic 15

Lipid profile testing IVD 11.2% cardiology share 2022.

Statistic 16

Thyroid testing IVD 9.7% endocrinology share 2022.

Statistic 17

CRP testing in inflammation IVD 8.4% share 2022.

Statistic 18

PSA testing oncology IVD 12.5% share 2022.

Statistic 19

HbA1c diabetes IVD 16.3% share 2022.

Statistic 20

Vitamin D testing 10.1% endocrinology IVD 2022.

Statistic 21

Troponin cardiac biomarkers 14.9% share 2022.

Statistic 22

D-dimer thrombosis IVD 11.7% share 2022.

Statistic 23

Influenza rapid tests 22.3% respiratory IVD 2022.

Statistic 24

BNP/NT-proBNP heart failure IVD 13.2% 2022.

Statistic 25

CA-125 ovarian cancer marker 9.4% oncology IVD 2022.

Statistic 26

Ferritin iron deficiency IVD 7.8% hematology 2022.

Statistic 27

Roche Diagnostics held the leading position in the IVD market with approximately 15% market share in 2022.

Statistic 28

Abbott Laboratories captured 12.8% of the global IVD market revenue in 2022.

Statistic 29

Siemens Healthineers market share in IVD stood at 11.2% globally in 2022.

Statistic 30

Danaher Corporation (Beckman Coulter) had 9.5% IVD market share in 2022.

Statistic 31

Thermo Fisher Scientific occupied 8.7% of global IVD market in 2022.

Statistic 32

Bio-Rad Laboratories held 6.4% share in IVD reagents market in 2022.

Statistic 33

Ortho Clinical Diagnostics market share was 5.9% in 2022 globally.

Statistic 34

Becton Dickinson & Co. had 7.1% IVD market share in 2022.

Statistic 35

Arkray Inc. captured niche 3.2% in glucose monitoring IVD segment 2022.

Statistic 36

Hologic Inc. market share 4.8% in women's health IVD 2022.

Statistic 37

bioMérieux SA held 6.9% in microbiology IVD segment 2022.

Statistic 38

Qiagen NV market share 5.3% in molecular diagnostics IVD 2022.

Statistic 39

Sysmex Corporation 7.6% share in hematology analyzers 2022.

Statistic 40

LumiraDx Ltd. emerging with 2.1% in POCT IVD 2022.

Statistic 41

DiaSorin S.p.A. 5.7% share in immunoassay IVD 2022.

Statistic 42

Response Biomedical Corp. 1.8% in cardiac POCT IVD 2022.

Statistic 43

Eiken Chemical Co. 3.9% in TB diagnostics IVD 2022.

Statistic 44

Fujirebio Inc. 4.2% share in tumor markers IVD 2022.

Statistic 45

Immucor Inc. 2.9% in transfusion diagnostics IVD 2022.

Statistic 46

Grifols SA 6.2% share in coagulation IVD 2022.

Statistic 47

Bio-Rad Laboratories 6.4% overall IVD share reiterated 2022.

Statistic 48

Accelerate Diagnostics Inc. 1.5% emerging tech share 2022.

Statistic 49

Meridian Bioscience 3.6% in molecular POCT IVD 2022.

Statistic 50

BioFire Diagnostics (bioMérieux) 4.1% PCR panel share 2022.

Statistic 51

GenMark Diagnostics 2.7% syndromic panel IVD 2022.

Statistic 52

Alere Inc. (Abbott) 8.2% POCT share 2022.

Statistic 53

Global in vitro diagnostics (IVD) market size was valued at USD 84.5 billion in 2022 and is expected to grow at a CAGR of 4.2% from 2023 to 2030.

Statistic 54

IVD reagents segment generated revenue of USD 49.2 billion in 2022, representing the largest product segment.

Statistic 55

U.S. IVD market size reached USD 35.6 billion in 2022, with a projected CAGR of 4.5% to 2030.

Statistic 56

Global IVD market projected to reach USD 123.5 billion by 2030 at 4.9% CAGR from 2023 base.

Statistic 57

IVD point-of-care testing market size was USD 28.4 billion in 2022, growing at 7.1% CAGR.

Statistic 58

European IVD market size stood at USD 22.3 billion in 2022 with steady growth.

Statistic 59

Global IVD software market within the industry was USD 4.1 billion in 2022.

Statistic 60

IVD consumables market size estimated at USD 55.7 billion in 2023 projection.

Statistic 61

Lab-based IVD testing dominated with 68.4% revenue share in 2022 globally.

Statistic 62

POCT IVD market expected to hit USD 49.3 billion by 2028 at 8.6% CAGR.

Statistic 63

Self-testing IVD kits market USD 6.7 billion in 2022 globally.

Statistic 64

Digital IVD market integration projected USD 12.4 billion by 2030.

Statistic 65

Hospital end-use segment 55.3% IVD market share in 2022.

Statistic 66

Over-the-counter IVD market USD 8.9 billion projected 2023.

Statistic 67

IVD market for NGS-based tests USD 3.6 billion in 2022.

Statistic 68

Companion diagnostics IVD market USD 7.1 billion 2022 growth.

Statistic 69

IVD AI integration market projected USD 2.5 billion by 2027.

Statistic 70

Home-based IVD testing market USD 15.4 billion 2022.

Statistic 71

IVD for pharmacogenomics USD 1.9 billion 2022.

Statistic 72

Centralized lab IVD services USD 40.2 billion 2022.

Statistic 73

IVD newborn screening market USD 1.2 billion 2022.

Statistic 74

Remote diagnostics IVD trend USD 4.7 billion projection 2023.

Statistic 75

IVD CRISPR diagnostics market nascent USD 0.8 billion 2022.

Statistic 76

IVD for rare diseases USD 2.2 billion 2022.

Statistic 77

Wearable-integrated IVD sensors USD 1.4 billion emerging 2022.

Statistic 78

IVD telemedicine linkage market USD 3.3 billion 2022.

Statistic 79

Clinical chemistry segment dominated the IVD market with a revenue share of 52.3% in 2022 due to high demand for routine testing.

Statistic 80

Immunoassay analyzers segment accounted for 38.5% of the IVD instruments market in 2022.

Statistic 81

Molecular diagnostics segment in IVD market valued at USD 18.7 billion in 2022.

Statistic 82

Fully automated analyzers held 45.2% share in IVD systems market in 2022.

Statistic 83

Microbiology IVD segment revenue reached USD 14.2 billion in 2022.

Statistic 84

Tissue diagnostics segment in IVD valued at USD 7.8 billion in 2022.

Statistic 85

Hematology analyzers segment captured 31.6% of IVD instruments in 2022.

Statistic 86

Coagulation testing segment revenue USD 9.3 billion in IVD 2022.

Statistic 87

ELISA tests in immunoassay segment held 42.1% share in 2022.

Statistic 88

PCR-based molecular diagnostics revenue USD 10.5 billion in 2022.

Statistic 89

Chemiluminescence immunoassay led with 35.7% in reagents 2022.

Statistic 90

Urinalysis products segment USD 5.4 billion revenue 2022.

Statistic 91

Flow cytometry analyzers 22.4% in immunology products 2022.

Statistic 92

Biosensors in POCT IVD generated USD 9.2 billion 2022.

Statistic 93

Lateral flow assays in rapid tests 28.5% segment share 2022.

Statistic 94

Glucose monitoring strips USD 11.8 billion revenue 2022.

Statistic 95

Mass spectrometry reagents USD 2.3 billion in IVD 2022.

Statistic 96

Western blot tests 18.2% in protein diagnostics 2022.

Statistic 97

Turbidimetry methods 26.1% clinical chemistry share 2022.

Statistic 98

Microarrays in genomics IVD USD 3.1 billion 2022.

Statistic 99

Nephelometry in immunoassays 19.8% share 2022.

Statistic 100

Electrochemical sensors 33.4% POCT segment 2022.

Statistic 101

Real-time PCR instruments USD 4.9 billion 2022.

Statistic 102

Immunoturbidimetric assays 24.6% clinical chem 2022.

Statistic 103

Digital PCR tech USD 5.2 billion forecast base 2022.

Statistic 104

Blotting techniques 15.9% molecular IVD 2022.

Statistic 105

The IVD market in North America accounted for over 41% revenue share in 2022, driven by advanced healthcare infrastructure.

Statistic 106

Europe IVD market is projected to grow at a CAGR of 5.1% from 2023 to 2028, supported by aging population.

Statistic 107

Asia Pacific IVD market grew at 6.8% CAGR from 2018-2022, fastest regionally due to rising healthcare access.

Statistic 108

China IVD market valued at USD 12.1 billion in 2022, with 8.2% annual growth.

Statistic 109

Latin America IVD market expected to grow at 5.5% CAGR to 2030 from emerging economies.

Statistic 110

Middle East & Africa IVD market CAGR projected at 6.3% from 2023-2028.

Statistic 111

Japan IVD market grew at 4.8% CAGR over 2019-2022 period.

Statistic 112

India IVD market valued at USD 1.9 billion in 2022 with rapid urbanization boost.

Statistic 113

Germany IVD market size USD 5.2 billion in 2022, leader in Europe.

Statistic 114

Brazil IVD market grew 5.9% annually 2020-2022.

Statistic 115

South Korea IVD market CAGR 7.2% from 2021-2022.

Statistic 116

Australia IVD market size USD 2.1 billion in 2022.

Statistic 117

UK IVD market valued at USD 4.3 billion 2022.

Statistic 118

Mexico IVD market CAGR 6.1% 2020-2022.

Statistic 119

France IVD market size USD 3.9 billion 2022.

Statistic 120

Canada IVD market USD 3.2 billion in 2022.

Statistic 121

Italy IVD market CAGR 4.7% 2019-2022.

Statistic 122

Spain IVD market size USD 2.8 billion 2022.

Statistic 123

Netherlands IVD market grew 5.3% CAGR recent years.

Statistic 124

Russia IVD market USD 2.4 billion despite challenges 2022.

Statistic 125

Turkey IVD market CAGR 7.4% 2020-2022.

Statistic 126

Saudi Arabia IVD market size USD 1.5 billion 2022.

Statistic 127

UAE IVD market grew 6.9% annually recent period.

Statistic 128

Argentina IVD market USD 1.1 billion 2022.

Statistic 129

Poland IVD market CAGR 5.8% 2021-2022.

Statistic 130

Egypt IVD market size USD 0.9 billion 2022.

Sources
Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Beneath the surface of every routine blood test and rapid diagnostic lies an $84.5 billion global industry, where a handful of powerful companies and relentless technological innovation are reshaping how we detect and manage disease.

Key Takeaways

  • Global in vitro diagnostics (IVD) market size was valued at USD 84.5 billion in 2022 and is expected to grow at a CAGR of 4.2% from 2023 to 2030.
  • IVD reagents segment generated revenue of USD 49.2 billion in 2022, representing the largest product segment.
  • U.S. IVD market size reached USD 35.6 billion in 2022, with a projected CAGR of 4.5% to 2030.
  • The IVD market in North America accounted for over 41% revenue share in 2022, driven by advanced healthcare infrastructure.
  • Europe IVD market is projected to grow at a CAGR of 5.1% from 2023 to 2028, supported by aging population.
  • Asia Pacific IVD market grew at 6.8% CAGR from 2018-2022, fastest regionally due to rising healthcare access.
  • Clinical chemistry segment dominated the IVD market with a revenue share of 52.3% in 2022 due to high demand for routine testing.
  • Immunoassay analyzers segment accounted for 38.5% of the IVD instruments market in 2022.
  • Molecular diagnostics segment in IVD market valued at USD 18.7 billion in 2022.
  • Infectious diseases application held the largest market share of 28.4% in the IVD market in 2022, boosted by COVID-19 diagnostics.
  • Oncology IVD market share was 22.1% in 2022 within disease diagnostics applications.
  • Diabetes management IVD applications generated USD 12.4 billion in revenue in 2022.
  • Roche Diagnostics held the leading position in the IVD market with approximately 15% market share in 2022.
  • Abbott Laboratories captured 12.8% of the global IVD market revenue in 2022.
  • Siemens Healthineers market share in IVD stood at 11.2% globally in 2022.

The IVD diagnostics market is large, growing steadily, and dominated by reagents and routine testing.

Application Segments

1Infectious diseases application held the largest market share of 28.4% in the IVD market in 2022, boosted by COVID-19 diagnostics.
Verified
2Oncology IVD market share was 22.1% in 2022 within disease diagnostics applications.
Verified
3Diabetes management IVD applications generated USD 12.4 billion in revenue in 2022.
Verified
4Cardiology diagnostics in IVD accounted for 15.7% application market share in 2022.
Directional
5Autoimmune diseases IVD testing market share was 11.3% in 2022.
Single source
6Nephrology IVD applications contributed 9.2% market share in 2022.
Verified
7Neurology diagnostics IVD share was 7.5% in 2022 applications.
Verified
8Gastroenterology IVD market share 6.8% in 2022.
Verified
9Respiratory diseases IVD testing surged to 18.9% share post-COVID in 2022.
Directional
10Drug testing IVD applications 10.4% market share in 2022.
Single source
11Endocrinology IVD testing 13.6% share in 2022 applications.
Verified
12Rheumatology IVD share 5.2% in 2022.
Verified
13Hematology testing IVD 14.8% application share 2022.
Verified
14Infectious disease POCT 42.7% share in applications 2022.
Directional
15Lipid profile testing IVD 11.2% cardiology share 2022.
Single source
16Thyroid testing IVD 9.7% endocrinology share 2022.
Verified
17CRP testing in inflammation IVD 8.4% share 2022.
Verified
18PSA testing oncology IVD 12.5% share 2022.
Verified
19HbA1c diabetes IVD 16.3% share 2022.
Directional
20Vitamin D testing 10.1% endocrinology IVD 2022.
Single source
21Troponin cardiac biomarkers 14.9% share 2022.
Verified
22D-dimer thrombosis IVD 11.7% share 2022.
Verified
23Influenza rapid tests 22.3% respiratory IVD 2022.
Verified
24BNP/NT-proBNP heart failure IVD 13.2% 2022.
Directional
25CA-125 ovarian cancer marker 9.4% oncology IVD 2022.
Single source
26Ferritin iron deficiency IVD 7.8% hematology 2022.
Verified

Application Segments Interpretation

The IVD market's 2022 story reads like a medical drama: infectious diseases seized the starring role thanks to COVID-19, while oncology played a formidable supporting character, and every other specialty—from cardiology to endocrinology—jostled for a piece of the diagnostic revenue pie.

Competitive Landscape

1Roche Diagnostics held the leading position in the IVD market with approximately 15% market share in 2022.
Verified
2Abbott Laboratories captured 12.8% of the global IVD market revenue in 2022.
Verified
3Siemens Healthineers market share in IVD stood at 11.2% globally in 2022.
Verified
4Danaher Corporation (Beckman Coulter) had 9.5% IVD market share in 2022.
Directional
5Thermo Fisher Scientific occupied 8.7% of global IVD market in 2022.
Single source
6Bio-Rad Laboratories held 6.4% share in IVD reagents market in 2022.
Verified
7Ortho Clinical Diagnostics market share was 5.9% in 2022 globally.
Verified
8Becton Dickinson & Co. had 7.1% IVD market share in 2022.
Verified
9Arkray Inc. captured niche 3.2% in glucose monitoring IVD segment 2022.
Directional
10Hologic Inc. market share 4.8% in women's health IVD 2022.
Single source
11bioMérieux SA held 6.9% in microbiology IVD segment 2022.
Verified
12Qiagen NV market share 5.3% in molecular diagnostics IVD 2022.
Verified
13Sysmex Corporation 7.6% share in hematology analyzers 2022.
Verified
14LumiraDx Ltd. emerging with 2.1% in POCT IVD 2022.
Directional
15DiaSorin S.p.A. 5.7% share in immunoassay IVD 2022.
Single source
16Response Biomedical Corp. 1.8% in cardiac POCT IVD 2022.
Verified
17Eiken Chemical Co. 3.9% in TB diagnostics IVD 2022.
Verified
18Fujirebio Inc. 4.2% share in tumor markers IVD 2022.
Verified
19Immucor Inc. 2.9% in transfusion diagnostics IVD 2022.
Directional
20Grifols SA 6.2% share in coagulation IVD 2022.
Single source
21Bio-Rad Laboratories 6.4% overall IVD share reiterated 2022.
Verified
22Accelerate Diagnostics Inc. 1.5% emerging tech share 2022.
Verified
23Meridian Bioscience 3.6% in molecular POCT IVD 2022.
Verified
24BioFire Diagnostics (bioMérieux) 4.1% PCR panel share 2022.
Directional
25GenMark Diagnostics 2.7% syndromic panel IVD 2022.
Single source
26Alere Inc. (Abbott) 8.2% POCT share 2022.
Verified

Competitive Landscape Interpretation

It appears Roche still runs the diagnostic world, but the sheer number of specialists carving out their own kingdoms suggests the throne room is getting awfully crowded.

Market Size and Growth

1Global in vitro diagnostics (IVD) market size was valued at USD 84.5 billion in 2022 and is expected to grow at a CAGR of 4.2% from 2023 to 2030.
Verified
2IVD reagents segment generated revenue of USD 49.2 billion in 2022, representing the largest product segment.
Verified
3U.S. IVD market size reached USD 35.6 billion in 2022, with a projected CAGR of 4.5% to 2030.
Verified
4Global IVD market projected to reach USD 123.5 billion by 2030 at 4.9% CAGR from 2023 base.
Directional
5IVD point-of-care testing market size was USD 28.4 billion in 2022, growing at 7.1% CAGR.
Single source
6European IVD market size stood at USD 22.3 billion in 2022 with steady growth.
Verified
7Global IVD software market within the industry was USD 4.1 billion in 2022.
Verified
8IVD consumables market size estimated at USD 55.7 billion in 2023 projection.
Verified
9Lab-based IVD testing dominated with 68.4% revenue share in 2022 globally.
Directional
10POCT IVD market expected to hit USD 49.3 billion by 2028 at 8.6% CAGR.
Single source
11Self-testing IVD kits market USD 6.7 billion in 2022 globally.
Verified
12Digital IVD market integration projected USD 12.4 billion by 2030.
Verified
13Hospital end-use segment 55.3% IVD market share in 2022.
Verified
14Over-the-counter IVD market USD 8.9 billion projected 2023.
Directional
15IVD market for NGS-based tests USD 3.6 billion in 2022.
Single source
16Companion diagnostics IVD market USD 7.1 billion 2022 growth.
Verified
17IVD AI integration market projected USD 2.5 billion by 2027.
Verified
18Home-based IVD testing market USD 15.4 billion 2022.
Verified
19IVD for pharmacogenomics USD 1.9 billion 2022.
Directional
20Centralized lab IVD services USD 40.2 billion 2022.
Single source
21IVD newborn screening market USD 1.2 billion 2022.
Verified
22Remote diagnostics IVD trend USD 4.7 billion projection 2023.
Verified
23IVD CRISPR diagnostics market nascent USD 0.8 billion 2022.
Verified
24IVD for rare diseases USD 2.2 billion 2022.
Directional
25Wearable-integrated IVD sensors USD 1.4 billion emerging 2022.
Single source
26IVD telemedicine linkage market USD 3.3 billion 2022.
Verified

Market Size and Growth Interpretation

The global IVD industry, now an $84.5 billion behemoth, is quietly staging a revolution from within, as the humble lab coat is being steadily outflanked by the nimble, at-home test kit and the supercharged software, all racing toward a future where the diagnosis increasingly meets you right where you are.

Product Segments

1Clinical chemistry segment dominated the IVD market with a revenue share of 52.3% in 2022 due to high demand for routine testing.
Verified
2Immunoassay analyzers segment accounted for 38.5% of the IVD instruments market in 2022.
Verified
3Molecular diagnostics segment in IVD market valued at USD 18.7 billion in 2022.
Verified
4Fully automated analyzers held 45.2% share in IVD systems market in 2022.
Directional
5Microbiology IVD segment revenue reached USD 14.2 billion in 2022.
Single source
6Tissue diagnostics segment in IVD valued at USD 7.8 billion in 2022.
Verified
7Hematology analyzers segment captured 31.6% of IVD instruments in 2022.
Verified
8Coagulation testing segment revenue USD 9.3 billion in IVD 2022.
Verified
9ELISA tests in immunoassay segment held 42.1% share in 2022.
Directional
10PCR-based molecular diagnostics revenue USD 10.5 billion in 2022.
Single source
11Chemiluminescence immunoassay led with 35.7% in reagents 2022.
Verified
12Urinalysis products segment USD 5.4 billion revenue 2022.
Verified
13Flow cytometry analyzers 22.4% in immunology products 2022.
Verified
14Biosensors in POCT IVD generated USD 9.2 billion 2022.
Directional
15Lateral flow assays in rapid tests 28.5% segment share 2022.
Single source
16Glucose monitoring strips USD 11.8 billion revenue 2022.
Verified
17Mass spectrometry reagents USD 2.3 billion in IVD 2022.
Verified
18Western blot tests 18.2% in protein diagnostics 2022.
Verified
19Turbidimetry methods 26.1% clinical chemistry share 2022.
Directional
20Microarrays in genomics IVD USD 3.1 billion 2022.
Single source
21Nephelometry in immunoassays 19.8% share 2022.
Verified
22Electrochemical sensors 33.4% POCT segment 2022.
Verified
23Real-time PCR instruments USD 4.9 billion 2022.
Verified
24Immunoturbidimetric assays 24.6% clinical chem 2022.
Directional
25Digital PCR tech USD 5.2 billion forecast base 2022.
Single source
26Blotting techniques 15.9% molecular IVD 2022.
Verified

Product Segments Interpretation

While clinical chemistry still rules the testing kingdom by bulk demand, a closer look reveals a bustling and specialized court where immunoassay generals, molecular diagnostics wizards, and automated machine overlords all vie for their own lucrative slices of the diagnostic pie.

Regional Markets

1The IVD market in North America accounted for over 41% revenue share in 2022, driven by advanced healthcare infrastructure.
Verified
2Europe IVD market is projected to grow at a CAGR of 5.1% from 2023 to 2028, supported by aging population.
Verified
3Asia Pacific IVD market grew at 6.8% CAGR from 2018-2022, fastest regionally due to rising healthcare access.
Verified
4China IVD market valued at USD 12.1 billion in 2022, with 8.2% annual growth.
Directional
5Latin America IVD market expected to grow at 5.5% CAGR to 2030 from emerging economies.
Single source
6Middle East & Africa IVD market CAGR projected at 6.3% from 2023-2028.
Verified
7Japan IVD market grew at 4.8% CAGR over 2019-2022 period.
Verified
8India IVD market valued at USD 1.9 billion in 2022 with rapid urbanization boost.
Verified
9Germany IVD market size USD 5.2 billion in 2022, leader in Europe.
Directional
10Brazil IVD market grew 5.9% annually 2020-2022.
Single source
11South Korea IVD market CAGR 7.2% from 2021-2022.
Verified
12Australia IVD market size USD 2.1 billion in 2022.
Verified
13UK IVD market valued at USD 4.3 billion 2022.
Verified
14Mexico IVD market CAGR 6.1% 2020-2022.
Directional
15France IVD market size USD 3.9 billion 2022.
Single source
16Canada IVD market USD 3.2 billion in 2022.
Verified
17Italy IVD market CAGR 4.7% 2019-2022.
Verified
18Spain IVD market size USD 2.8 billion 2022.
Verified
19Netherlands IVD market grew 5.3% CAGR recent years.
Directional
20Russia IVD market USD 2.4 billion despite challenges 2022.
Single source
21Turkey IVD market CAGR 7.4% 2020-2022.
Verified
22Saudi Arabia IVD market size USD 1.5 billion 2022.
Verified
23UAE IVD market grew 6.9% annually recent period.
Verified
24Argentina IVD market USD 1.1 billion 2022.
Directional
25Poland IVD market CAGR 5.8% 2021-2022.
Single source
26Egypt IVD market size USD 0.9 billion 2022.
Verified

Regional Markets Interpretation

While North America's massive and well-equipped IVD market remains the wealthy grandparent of the industry, the true global pulse is quickening fastest in the ambitious, access-seeking patients of Asia Pacific and the emerging economies, proving that diagnostics are no longer a luxury but a global necessity.